Transcript Highlights:

• I strongly recommend checking out the Psychedelic Medicine Task Force committee legislative report.
• I strongly recommend checking out the Psychedelic Medicine Task Force committee legislative report.
• I am a U.S. elected member of the Minnesota Psychedelic Task Force, convened in 2023.
• For the past three testifiers, psychedelic-assisted psychotherapy helped me get better personally.
• I'm certified in psilocybin and psychedelic-assisted therapies Minneapolis area.

Bills: HF3454, HF3917, HF2906, HF3832, HF3769

Keywords: social work, licensure, employment titles, health occupations, professional standards, medication repository, drug donation, healthcare, Minnesota Statutes, pharmacy, public health, controlled substances, psilocybin, psilocin, psychedelic, psychedelic medicine, hallucinogen, mushrooms, magic mushrooms, therapeutic use

Transcript Highlights:

• medicine task force put out psychedelic medicine task force put out in<00:42:57.119> uh<00:42
• Chair, members, I am here today in support of the Psychedelic Access Project.
• As I stated, I am a co-founder and board director of the Psychedelic Access Project.
• I was appointed by the governor in 2023 and elected to serve as the chair of the psychedelic medicine
• medicines up to the other psychedelic medicines up to the end<00:48:01.200> of<00:48:01.359><

Bills: HF4588, HF3685, HF4577, HF4932

Keywords: veterans, veterans affairs, mental health, behavioral health, rural health, rural areas, access to care, task force, Minnesota Department of Veterans Affairs, general fund appropriation, veteran suicide prevention, PTSD, service members, military families, telehealth, rural psychiatry, high school diploma, armed forces, education policy, military service

Bills: SB1071, SB1315, SB1317, SB1416, SB1493, SB1537, SB1542, SB1584, SB1626, SB1740, SB1751, SB1804, SCR1047, SCR1049

Keywords: Arizona Rangers, statutory repeal, security, state law, regulatory changes, school safety, interoperable communications, law enforcement, emergency response, funding, reentry programs, criminal justice, grants, recidivism, attorney general, missing children, kidnapping, reporting requirements, child safety, training

Summary: The committee first took up SB 1071, which would repeal the statutory framework for the Arizona Rangers. The sponsor argued the bill was about accountability and transparency, citing concerns about missing training and firearms qualification records; Arizona Rangers representatives and several sheriffs opposed the bill, saying the Rangers provide valuable volunteer support and that the real issue was adding oversight rather than eliminating protections. After discussion, the committee voted 4-3 to give SB 1071 a do pass recommendation, with members noting they expected amendments later. The committee then heard SB 1315, requiring school districts and charter schools to maintain interoperable emergency communications with law enforcement and to submit annual affidavits confirming testing and compliance. Testimony from school safety officials and sheriffs emphasized the value of real-time communication during emergencies and the need for secure sharing of campus maps and floor plans; concerns about cost and information security were addressed by supporters. The bill passed unanimously, 7-0. The committee also advanced SB 1317, which appropriates opioid settlement funds for county reentry planning programs; sheriffs and association representatives supported it, citing reduced recidivism and jail populations, and it passed 7-0. Several public safety and missing-children measures were considered next. SB 1416, as amended, revises missing child reporting requirements, adds runaway children back into reporting, requires faster photo and information sharing, and expands training requirements; advocates for missing children and law enforcement supported the compromise language, and the bill passed 7-0. SB 1740, which updates Turquoise Alert training and procedures, was also advanced 7-0 after discussion about statewide versus geographically targeted alerts and the need to keep alerts effective. Later, SB 1493, a strike-everything amendment affecting police officer termination appeals and fee shifting when an employer rejects a favorable administrative ruling, passed 5-2 despite opposition from chiefs’ representatives. SB 1537, renaming the Peace Officer Training Equipment Fund and repealing its advisory commission, passed 5-2. The committee also approved SB 1751 and SCR 1049, which expand execution methods to include lethal gas and firing squad and make firing squad mandatory in certain cases involving the murder of a law enforcement officer; opponents raised constitutional, ethical, and practical concerns, while supporters framed the measures as aligning Arizona with other states and providing additional options. Both measures passed 4-3. Finally, SB 1542, which would create a framework and funding for MDMA research and treatment for PTSD in first responders and peace officers contingent on FDA approval, was heard with testimony describing promising clinical trial results and the need for Arizona research; the bill was then moved forward, though the transcript cuts off before the final roll call result is fully shown.

Bills: HB199, HB222, HB223, HB224, HB235, HB246, HB405, HB535, HB554, HB907, SCR3, SB43, SB52, SB54, SB113, SB168, SB219, SB222, SB270, SB311, SB359

Keywords: nursing facilities, moratorium, healthcare, patient care, data collection, Medicaid, dental coverage, healthcare access, medical necessity, Louisiana Department of Health, Department of Children and Family Services, sunset law, statutory entities, regulatory authority, re-creation, termination dates, child welfare, foster care, children's rights, legal guardianship

Transcript Highlights:

• Just from what we shared today, psychedelics and psychedelic-assisted therapy should probably become
• I began in DMT or among the most powerful psychedelic substances on earth.
• Many still equate the language of psychedelics with harm and incarceration.
• And three, psychedelics need a legal path.
• And three, psychedelics need a legal path.

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• So as of early to mid-2025, over 60 bills related to psychedelic policy reform have been...
• The total number of psychedelic bills considered by states since 2019 has exceeded...
• Timely state research of psychedelic treatments upon FDA approval and DEA rescheduling.
• When combined with psychological support, psychedelic compounds... ...strides.
• Now, we have multiple investigative psychedelic treatments in late-stage FDA review.

Keywords: 1182, all

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.

Transcript Highlights:

• development, or pharmaceutical companies, to use psychedelics under strict supervision.
• Federally, the FDA has assigned its breakthrough therapy designation to multiple psychedelics.
• Unfortunately, this new frontier of psychedelic treatment has become the Wild Wild West.
• We provide a progressive, integrated, and structured approach to psychedelic therapy.
• Thank you. reference psychedelics in general and does not seem to be very narrowly focused.

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.

Transcript Highlights:

• <00:57:37.240> um psychedelics um psychedelics um over<00:57:38.960> the<00:57:39.040><
• That's that's the goal of psychedelic That's that's the goal of psychedelic assisted<00:57:56.760
• I learned of promising psychedelic I learned of promising psychedelic research<01:13:45.400>
• <01:19:43.760> assisted access legal psychedelic assisted access legal psychedelic assisted
• intimately involved in psychedelic intimately involved in psychedelic assisted<01:19:52.600>

Bills: HB1626, HB1643, HB1668, HB1550, HB1974, HB1858, HB1871, HB1966, HB1972, HB1973

Keywords: youth penalties, juvenile justice, community service, fees and fines, Native Hawaiian, Pacific Islander, reform, court costs, cultural connection, pharmacy, pharmacist, pharmacy audit, audit reform, pharmacy benefit manager, PBM, recoupment, extrapolation, claims audit, pharmacy reimbursement, dispensing fee

Summary: The committee heard testimony on SB 847, which would create a Kauai pilot program allowing qualified psychologists limited authority to prescribe psychotropic medications. The Board of Psychology supported the bill’s intent but asked for amendments to delay the effective date or extend the pilot so rules could be written first, and to clarify the education/training language. Supporters, including the Hawaii Psychological Association, Hawaii Mental Health Coalition, and several psychologists, argued that prescribing psychologists have long safety records in other jurisdictions and that the pilot could improve access to care on Kauai, especially amid ongoing mental health needs and storm-related stress. They cited studies and examples from New Mexico, Louisiana, the Department of Defense, and other places. Opponents, including the Hawaii Medical Association, American Academy of Pediatrics, Queen’s Medical Center, and a Department of Health representative, said the bill needed substantial work, raised concerns about training, liability, and workforce impacts, and urged a team-based model with psychiatrist oversight rather than independent prescribing. Some testimony also referenced a GAO report, with witnesses disagreeing over its meaning and cost-effectiveness. No vote was taken during the discussion, and members asked questions about how the bill would address the workforce shortage and whether a psychiatrist on Kauai could already meet the need. The committee then moved to SB 2271 on hospital licensing and SB 2272 on home health care licensing. The Department of Health, the Healthcare Association of Hawaii, and the Hawaii State Council on Developmental Disabilities supported both measures, which were described as streamlining and clarifying licensing oversight by relying on accreditation or certification reports. A member asked whether the bill language on hospital accreditation reports was duplicative, and the response was that the second provision was intended to strengthen enforcement by requiring hospitals to provide the actual report to DOH. The committee did not take final action in the portion of the hearing provided, and the chair noted that all bills on the agenda would later be considered for decision-making.

Transcript Highlights:

• This bill meets the recommendations the legislature received from the Psychedelic Medicine Task Force
• I strongly recommend checking out the Psychedelic Medicine Task Force committee legislative report.
• I was appointed by the governor and elected to serve as chairperson for the Psychedelic Medicine Task
• My name is Stephanie Cann, selected member of the Minnesota Psychedelic Task Force convened in 2023.
• For the past three testifiers, psychedelic-assisted psychotherapy helped me get better personally.

Keywords: 1183, house

Transcript Highlights:

• That's when I stumbled upon studies about psychedelics.
• , including psychedelic therapy, which has shown... ...which has shown profound neuroregenerative and
• , including psychedelic therapy, which has shown... ...which has shown profound neuroregenerative and
• Psychedelic therapy, which has shown immense promise for mental health conditions affecting veterans.
• Christina Rodriguez is a registered nurse specializing in psychedelic-assisted therapy and behavioral

Keywords: 912, senate, all

Summary: The Health and Human Services Committee heard testimony on several measures related to child welfare, health care access, overdose response, disability services, and waste management. For SB 710 on child welfare, the Department of Human Services, the Office of Wellness and Resilience, the Attorney General’s office, and multiple advocacy groups testified in support, with the Governor’s office noting support but deferring to the Attorney General on implementation because of separation-of-powers concerns. For SB 952 on child welfare services, DHS, the Governor’s office, and child- and trauma-informed care advocates supported the bill, saying it would help families access services, provide basic material support, and reduce strain on the child welfare system. SB 954 on a home health services rate study also drew support, including from DHS, the Hawaii Healthcare Association, and a public testifier who said the study would help ensure funds reach low-income, disabled, and kupuna recipients. SB 957 on overdose prevention received support from the Department of Health and the Attorney General, who said overdose prevention centers are evidence-based but raised federal-law concerns and recommended amendments; the Hawaii Health and Harm Reduction Center and others also testified in support. The committee then moved to the 1:00 regular calendar and heard SB 850 on disability health disparity, which was supported by the Executive Office on Aging, the Hawaii State Council on Developmental Disabilities, the Hawaii Disability Rights Center, self-advocates, and others. Testimony emphasized that a disparity study could improve workforce development, training, and services for people with disabilities. SB 838 on continuous glucose monitoring drew support from health agencies and advocates, with testimony stressing that monitors can be critical for some diabetes patients. SB 829 on health care was supported by the Department of Health and health care stakeholders, who said it would help rotating physicians serve neighbor islands without local hospital privileges and align with CMS rules. SB 446 on waste management drew mixed testimony: the Department of Health and several public entities provided comments, the County of Maui opposed, and environmental advocates urged stronger aquifer protections and limits on ash reuse. During decision making, the committee adopted recommendations to pass SB 298, SB 322, SB 299, SB 450, SB 451, SB 949, SB 710, SB 957, SB 69, and SD 952 with various amendments, including technical changes, blank appropriations, and defective dates. SB 323, SB 324, SB 712, SB 950, SB 954, and SB 959 were deferred, largely because companion House measures were moving or similar Senate measures had already passed. The chair also announced recesses to find quorum and noted that some bills from the earlier Monday calendar were being deferred to avoid duplication.

Transcript Highlights:

• in clinical research of psychedelic in clinical research of psychedelic assisted<00:51:20.520>
• <00:56:11.440> assistant specializing in psychedelic assistant specializing in psychedelic
• cosmologies to work with psychedelic cosmologies to work with psychedelic plant<00:56:37.160>
• The use of psychedelic drugs?
• authorized the creation of a psychedelic authorized the creation of a psychedelic assistant<01:39

Keywords: 910, house, all

Transcript Highlights:

• SB 3199 is not just a bill to legalize psychedelic therapies.
• Most people think psychedelics are experience, but what's significant is the science.
• Most people think psychedelics are experience, but what's significant is the science.
• Ketamine was my introduction to legal psychedelics.
• That's how I was able to psychedelics.

Keywords: 912, senate, all

Summary: The committee heard testimony on SB 3025, relating to medical debt, with multiple organizations and individuals, including the Office of Wellness and Resilience, Healthcare Association of Hawaii, Queens Health Systems, the American Cancer Society Cancer Action Network, Aloha Care, Hawaii Health and Harm Reduction, Hawaii Data Collaborative, and Hawaii Appleseed, all speaking in support. No opposition was heard, and the member present had no questions. The committee then took up SB 3199, which would establish a mental health emerging therapies task force. Testimony was overwhelmingly in support, with speakers including veterans, clinicians, researchers, and advocacy groups describing personal experiences with PTSD, depression, traumatic brain injury, and treatment-resistant conditions, and arguing that Hawaii should prepare for regulated access to emerging therapies such as MDMA, psilocybin, ketamine, and ibogaine. The Department of Health and some medical organizations provided comments, and one opposition witness was called but not present. The chair noted broad support, especially from veterans, and no vote was taken during the excerpt. The final measure discussed was SB 3324, relating to Medicaid. The Department of Human Services, Department of Health, Hawaii State Council on Developmental Disabilities, Hawaii Disability Rights Center, Aloha Care, and numerous care-provider and aging/disability organizations testified in support, while one witness was in opposition and several others offered comments. The discussion then moved to SB 2563, relating to homelessness, where the Department of the Attorney General offered comments on specific sections and recommended adopting suggested amendments if the bill proceeds. Additional testimony on SB 2563 began with support from several individuals, including Shelby Pikachu, who emphasized the severity of homelessness and related social problems in the community.

Transcript Highlights:

• Um, it's a psychedelic.
• Uh the highs that it's a psychedelic.
• <02:28:10.960> and people get from uh psychedelics and people get from uh psychedelics and
• That's other psychedelics is ongoing, but even other psychedelics is ongoing, but even the<02:31:58.240
• > organizations psychedelics and recovery organizations psychedelics and recovery organizations out

Keywords: 1191, senate, all

Transcript Highlights:

• What they call magic mushrooms, psychedelic mushrooms. Psychedelic mushrooms grow in all 50 states.
• <05:38:43.280> mushrooms<05:38:44.160> psilocybin psychedelic mushrooms psilocybin psychedelic
• arrest people for psychedelics arrest people for psychedelics possession<05:42:22.718> and
• <05:51:05.558> therapy FDA has not approved psychedelic therapy FDA has not approved psychedelic
• None of them mentioned psychedelics at all.

Keywords: 1189, house, all

Transcript Highlights:

• nurse specializing in psychedelic nurse specializing in psychedelic assisted<01:15:45.679> therapy
• <01:16:26.199> plant mind and hearts in the Psychedelic plant mind and hearts in the Psychedelic
• and practiced for Millennia psychedelic and practiced for Millennia psychedelic plant<01:16:45.920
• I am alive today because of those therapies, despite anyone's opinions on psychedelics.
• That same year, there were many headlines about psychedelic medicine and veterans.

Keywords: 910, house, all

Summary: The Committee on Health heard testimony on several bills. On SB 1441, which would repeal the transfer of the Oahu Regional Health Care System from HHSC to the Department of Health, the Department of Health said it strongly supports the measure and requested clarifying amendments. HHSC/Oahu Region also supported the bill and said it had no objection to the department’s amendments. In response to questions, witnesses said the agencies have been working on an MOU to support transfers of long-term care patients to Leahi, with the current goal being about 10 to 15 patients, but transfers would occur only as space and staffing allow; one patient was reportedly being admitted at the time, and the process was described as slow and case-by-case. The committee then heard SB 1443 on payment rates for state hospital patients and related Department of Health services. The hospital administrator said the bill would allow rates above Medicaid for community or foster-home placements if patients cannot be placed at Leahi or elsewhere, and would set Medicaid-level reimbursement for outside medical services used by state hospital patients. He said at least one provider was interested in offering services at that rate and that the population involved is largely non-ambulatory long-term care patients. Members asked about availability and training, and the witness said special training could be provided. SB 1322, a broad mental health bill, drew mixed testimony. The Department of Law Enforcement supported giving crisis-intervention-trained officers more discretion to transport people to medical care instead of arresting them. The Attorney General supported the bill but recommended revisions to emergency-transport language and restoring liability protections. HHSC and Queens Hospital supported the overall goal but sought amendments to preserve the mental health emergency worker role in decision-making and to avoid negative impacts on emergency departments. The Disability Rights Center and ACLU opposed parts of the bill, arguing that it weakens due process, reduces protections in involuntary treatment and transport, and should retain a three-person treatment panel rather than reduce it to one. A Queens representative said the current program works well and reported that more than 90% of MH1 cases once went to hospitals, but that figure has dropped to about 60-70%, with about 20% now diverted to community settings or the behavioral health crisis center. No votes or final committee actions were taken in the portion provided.

Transcript Highlights:

• recommendations from the psychedelic recommendations from the psychedelic medicine<02:08:54.239>
• bill also establishes a psychedelic bill also establishes a psychedelic medicine<02:10:32.239>
• recommendations of the psychedelic recommendations of the psychedelic medicine<02:13:15.440>
• of the psychedelic medicine board? of the psychedelic medicine board?
• concept applies for psychedelic motions. concept applies for psychedelic motions.

Keywords: 1187, senate, all

Transcript Highlights:

• knowledge, and ethical framework necessary to join other states in the responsible integration of psychedelic
• the last two years, I have held regular KAP groups for women, individual KAP sessions, as well as psychedelic
• Each of the various psychedelic medicines offer a different mechanism of action and various unique benefits
• the last two years, I have held regular KAP groups for women, individual KAP sessions, as well as psychedelic
• Each of the various psychedelic medicines offer a different mechanism of action and various unique benefits

Keywords: 995, all

Summary: The committee hearing covered a wide range of public health bills, with much of the testimony focused on two major themes: expanding access to care and stabilizing health-related workforces and services. On House 2364, an act relative to medical health and fitness facilities, representatives from Dedham Health and Athletic Club argued for a pilot program recognizing supervised exercise as medicine, saying it could improve outcomes for chronic disease, fall prevention, and mental health while reducing costs. On House/Senate bills concerning community health workers (H. 359/S. 251), multiple witnesses from MACHW, Health Care for All, MHA, Cambridge Health Alliance, Mass General Brigham, Boston Children’s Hospital, Asian Women for Health, and the City of Somerville described CHWs as essential for navigation, trust-building, language access, and addressing social needs, and urged reimbursement by MassHealth, the GIC, and private insurers, along with workforce development measures. One pediatric neurologist also told the committee that losing grant-funded CHW support led to more avoidable ER visits and threatened clinic operations. The committee also heard extensive testimony on hospital closures and essential services. Witnesses including Dr. Alan Sager, MNA President Katie Murphy, nurses from Brockton Hospital and Providence Behavioral Health, and local officials and legislators from Norwood described the loss of hospitals and service lines, especially maternity, pediatric, and behavioral health care, and argued current closure processes are too weak to protect communities. They supported bills such as H. 2460/S. 1503 and H. 2534/S. 1574, which would require earlier notice, community input, stronger state oversight, possible receivership, and limits on reopening or expanding after closures. Testimony emphasized the impact of Steward’s bankruptcy, the closures of Carney and Neshoba Valley, and the need to preserve access to essential services in underserved areas. Several end-of-life and professional regulation bills were also discussed. On H. 2436, Representative Omar Gomez and funeral industry witnesses supported eliminating Office of the Chief Medical Examiner fees for the removal of a child’s body in cases involving children five and under, describing the bill as a small but important relief for grieving families. On H. 2444 and related Senate bills, cemetery and consumer advocates supported legalizing alkaline hydrolysis and natural organic reduction as environmentally friendly after-death options, while cemetery representatives opposed H. 2360, which would allow funeral establishments to operate crematories, arguing cemeteries should retain that role. The committee also heard support for H. 2382, which would exempt dentists and oral surgeons from a new office-based surgical center framework, and for H. 2461, which would create hospital efficiency standards; employers and retailers backed that bill as a way to address rising health care costs. Finally, the committee heard testimony on autism services and hospital governance. On S. 1414, behavior analysts and school representatives said Massachusetts already licenses assistant-level ABA providers but MassHealth does not reimburse them, causing long waitlists and limiting school and family access; an actuary testified that a three-tier ABA reimbursement model could reduce MassHealth costs by up to 6% per child served. Senator Lovely also testified in support of S. 1572, which would require at least one registered nurse on each acute care hospital governing board, arguing nurses’ frontline perspective would improve quality and retention. No votes were taken in the hearing excerpt, but many witnesses urged favorable reports on their respective bills.

Transcript Highlights:

• I'm a psychedelic advocate who worked on the ballot campaign along with Graham to legalize psychedelics
• I'm a psychedelic advocate who worked on the ballot campaign along with Graham to legalize psychedelics
• psilocybin use without widespread negative outcomes, while the rest of the state continues to treat psychedelic

Keywords: 995, all

Summary: The Joint Committee on Revenue held a long hybrid hearing on a wide range of tax bills, with testimony covering cigarette and tobacco taxes, nicotine pouches, contractor rental equipment exemptions, aircraft sales tax exemptions, rolling stock, advanced sales tax payments, a gun and ammunition excise tax, a digital services tax, and a psilocybin cultivation/tax proposal. Committee chairs outlined the hearing process and noted that 39 House-filed sales and excise tax bills were being heard for required reporting by November 28. No votes were taken during the hearing. On tobacco-related bills, supporters including Senator Keenan, the American Heart Association, the American Cancer Society, and Tobacco Free Mass backed higher cigarette taxes and closing the synthetic nicotine loophole, arguing the measures would reduce youth initiation, encourage cessation, and offset health care costs. Retailers, wholesalers, and convenience-store groups opposed the increases, warning of smuggling, out-of-state purchasing, and harm to small businesses; premium cigar representatives argued cigars should be treated separately from cigarettes. The committee also heard testimony on H. 3067 and related bills concerning nicotine pouches, with public health advocates supporting taxation and industry witnesses urging a lower, more competitive rate. Several other bills drew sharply divided testimony. United Rentals supported H. 3065 to simplify contractor rental equipment exemption paperwork, while airport and aviation groups opposed bills to repeal the aircraft sales tax exemption, saying it would hurt airport competitiveness and jobs. The Transportation Association of Massachusetts backed rolling stock tax exemptions, saying the current tax discourages fleet investment and interstate commerce. Restaurant industry representatives supported repealing advanced sales tax payments and changing penalty rules, saying businesses were hit with retroactive penalties after unclear pandemic-era changes. On H. 3082, an excise tax on guns and ammunition, gun violence prevention advocates, Roca, and Giffords supported the bill as a dedicated funding source for prevention and survivor services, while sportsmen’s groups opposed it as unfair to lawful gun owners and harmful to conservation funding. The committee also heard testimony on H. 3208, a digital advertising services tax, with Representative Paulino supporting it as a way to capture revenue from online advertising and fund public needs, while the Chamber of Progress opposed it as costly and burdensome for small businesses and campaigns. Finally, multiple witnesses testified on H. 4050 regarding psilocybin cultivation and taxation: advocates from Mass Healing, Roca, the Reason Foundation, and individuals describing personal medical benefits urged a regulated, permit-based system, while the hearing ended after all signed-up speakers were heard and the chair adjourned the meeting.

Transcript Highlights:

• I'm working on my undergrad in psychology to eventually work with psychedelics professionally.
• I sought out help from an underground psychedelic therapist, and today I no longer drink alcohol, and
• The public has also made it clear that they oppose unregulated access to psychedelics with the defeat
• One in three frequent psychedelic users report driving under the influence of psychedelics in the past
• We believe the momentum in psychedelic research deserves to be supported, not constrained by policies

Keywords: 995, all

Summary: The committee opened with procedural guidance for a very large hearing, explaining testimony limits, written testimony procedures, and rules for maintaining order. Members then heard testimony on a wide range of bills, including proposals to define antisemitism using the IHRA definition, regulate facial recognition technology, restrict weaponized robotics and drone use, expand protections for journalists’ confidential sources, address access to decedents’ email accounts, and create or adjust rules around municipal enforcement and animal cruelty fines. Several sponsors and advocates asked for favorable reports, and committee members asked clarifying questions on implementation, costs, and how the bills would interact with existing law. On facial recognition, sponsors and advocates described the technology as a threat to privacy, due process, and civil liberties, and urged adoption of the Special Commission’s recommendations, including warrant requirements, notice to defendants, and limits on untargeted surveillance. Support came from legislators, the ACLU, CDT, EFF, and a UMass professor, while committee members asked about current state law and municipal bans. On robotics, Senator Moore and industry witnesses from MassRobotics, Boston Dynamics, and AUVSI supported a bill prohibiting weaponized robots and requiring warrants for certain law enforcement uses, describing it as a public-safety and trust-building measure. On the shield law bill, newspaper publishers, journalists, NEFAC, and the Reporters Committee argued Massachusetts needs statutory protection for confidential sources, citing costly subpoenas and chilling effects on reporting. The committee also heard testimony on a bill to expand the right of publicity to cover image and voice, with SAG-AFTRA members supporting protections against AI-driven exploitation and some discussion about viral content and consent. Another bill would allow limited access to a decedent’s email accounts, with one witness describing a family’s inability to use a deceased relative’s email to notify friends. The committee then took testimony on psilocybin-related bills: supporters described medical and personal benefits and argued for narrow decriminalization or study, while an opponent warned of public-health risks, impaired driving, and youth exposure; the Massachusetts Psychiatric Society supported limited, safety-based decriminalization. Finally, the committee heard strong support for a “safe reporting” bill for sex workers and trafficking survivors, with advocates saying immunity would encourage victims and witnesses to report crimes without fear of arrest, and members raised questions about how the immunity would work in practice.

Transcript Highlights:

• So psychedelics, kratom, 7-hydroxies, some of these new synthetic...
• So psychedelics, kratom, 7-hydroxies, some of these new synthetic opioids, the science is evolving on
• And then moving on to psychedelics, kratom products, hemp-derived cannabinoids, synthetic opioids.
• I'm delighted you're doing a meeting on psychedelics. I know a WashU team working on psychedelics.
• I know a WashU team working on psychedelics.

Summary: The task force meeting opened with new leadership announcements, including Senator Nick Schroer thanking outgoing chair Representative John Black and naming Representative Del Taylor as vice chair. After some initial technical difficulties with audio and Zoom, members reviewed the task force’s statutory charge under Missouri law: to hold hearings on substance use, explore solutions, draft or modify legislation, and produce recommendations for prevention and treatment. The chair said the goal for this year is to develop concrete legislative ideas for the next session, with hearings focused first on field experts and later on alternative therapies and the Department of Mental Health. Dr. Rachel Winograd gave the first major presentation, describing Missouri’s overdose crisis as increasingly complex and driven primarily by fentanyl, now compounded by xylazine and metatomidine. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, and attributed the decline to a smaller fentanyl supply, wider naloxone availability, and fewer young people entering use. Her main recommendations were to focus on reducing harm rather than trying to eliminate drug use, expand evidence-based medications for opioid use disorder—especially methadone and buprenorphine—improve access to naloxone, and loosen methadone regulations, including take-home doses, the federal 72-hour rule, and broader methadone units. She also emphasized that peer support, housing, transportation, and other practical supports matter, and noted that naloxone can still reverse fentanyl overdoses even when tranquilizers are present. Dr. Heidi Miller, the state medical director, followed with two recommendations: integrate substance use disorder care into whole-person health care and follow the science when considering substance-related legislation. She argued that primary care, maternal health, workforce training, EMS, public health, and methadone access should all be part of a coordinated model, and said reimbursement should support teams rather than isolated providers. She also urged stronger enforcement of parity between behavioral health/SUD and physical health coverage, and highlighted tobacco and alcohol as major, under-addressed causes of death in Missouri. Dr. Doug Burgess then reinforced the need for a coordinated continuum of care, comparing substance use treatment to the seamless system used for heart attacks, and said patients should have standardized assessment, discharge planning from day one, transition coordinators, peer recovery coaches, and better information-sharing between levels of care. Members asked questions about relapse, treatment court, EMS referral barriers, reimbursement, and whether buprenorphine can be started in the field; no votes were taken, and the meeting ended with plans to continue hearing testimony and use it to shape future policy recommendations.